ConductScience.org, home

Paper2311368

ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis.

Plaisier AP and 4 others. Comput Methods Programs Biomed, 1990. Cited by 117 papers, by iCite.

Cite this record

ConductScience Library. ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis. Papers, record 2311368. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2311368

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ONCHOSIM: a model and computer simulation program for the transmission and control of onchocerciasis.
PubMed
Journal
Comput Methods Programs Biomed
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
117
iCite
Relative citation ratio, by iCite
5.13
iCite
Revised in PubMed
2019-09-12
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Plaisier APA P
2van Oortmarssen GJG J
3Habbema JDJ D
4Remme JJ
5Alley ESE S

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Computer SimulationMajor topic
Insect VectorsMajor topic
Onchocerciasis, OcularMajor topic
SimuliidaeMajor topic
Animals
Humans
Microcomputers
Software

Source PubMed

Download CSV of topics

Cited by61

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.

PMIDTitleJournalYearIn PapersSource
42749698Modelling anti-Ov16 seroprevalence for the control and elimination of onchocerciasis.Nat Commun2026https://conductscience.org/library/papers/42749698PubMed
42539045Modelling the impact of mass drug administration with ivermectin or moxidectin on human onchocerciasis when there is sub-optimal response of parasites to treatment.Res Sq2026https://conductscience.org/library/papers/42539045PubMed
41671175Important entomological events in the history of onchocerciasis ('river blindness').Int Health2026https://conductscience.org/library/papers/41671175PubMed
39185442Inference of essential genes in Brugia malayi and Onchocerca volvulus by machine learning and the implications for discovering new interventions.Comput Struct Biotechnol J2024https://conductscience.org/library/papers/39185442PubMed
37235598Onchocerciasis-associated epilepsy in Maridi, South Sudan: Modelling and exploring the impact of control measures against river blindness.PLoS Negl Trop Dis2023https://conductscience.org/library/papers/37235598PubMed
35020729Demographic patterns of human antibody levels to Simulium damnosum s.l. saliva in onchocerciasis-endemic areas: An indicator of exposure to vector bites.PLoS Negl Trop Dis2022https://conductscience.org/library/papers/35020729PubMed
34310602The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.PLoS Negl Trop Dis2021https://conductscience.org/library/papers/34310602PubMed
34157020Human immune response against salivary antigens of Simulium damnosum s.l.: A new epidemiological marker for exposure to blackfly bites in onchocerciasis endemic areas.PLoS Negl Trop Dis2021https://conductscience.org/library/papers/34157020PubMed
34115752How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?PLoS Negl Trop Dis2021https://conductscience.org/library/papers/34115752PubMed
33979331The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages.PLoS Negl Trop Dis2021https://conductscience.org/library/papers/33979331PubMed
33289025Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas.Clin Infect Dis2021https://conductscience.org/library/papers/33289025PubMed
32173745Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring.J Infect Dis2020https://conductscience.org/library/papers/32173745PubMed
32043442The Interruption of Transmission of Human Onchocerciasis by an Annual Mass Drug Administration Program in Plateau and Nasarawa States, Nigeria.Am J Trop Med Hyg2020https://conductscience.org/library/papers/32043442PubMed
31805049Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs.PLoS Negl Trop Dis2019https://conductscience.org/library/papers/31805049PubMed
31304961Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025.Clin Infect Dis2020https://conductscience.org/library/papers/31304961PubMed
31062838Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis.Am J Epidemiol2019https://conductscience.org/library/papers/31062838PubMed
30646934Entomological assessment of the transmission following recrudescence of onchocerciasis in the Comoé Valley, Burkina Faso.Parasit Vectors2019https://conductscience.org/library/papers/30646934PubMed
30522129Predicted short and long-term impact of deworming and water, hygiene, and sanitation on transmission of soil-transmitted helminths.PLoS Negl Trop Dis2018https://conductscience.org/library/papers/30522129PubMed
30296264The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis.PLoS Negl Trop Dis2018https://conductscience.org/library/papers/30296264PubMed
30226900
Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
PLoS Negl Trop Dis2018https://conductscience.org/library/papers/30226900PubMed

See all 61 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2311368

GET https://conductscience.org/api/papers/v1/2311368/cited_by?page=2